TrialCNS drugs2024

An Open-Label Extension Study Assessing the Long-Term Safety and Efficacy of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder.

Ann Childress et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.